BPC-157 15mg
US$ 22.65
glow ghk cu tb 500 bpc 157 BPC-157 + TB-500 + GHK-Cu Blend BPC-157 TB-500 GHK-CU Blend (GLOW)
Description
Improves patient safety
The compound was never approved as a pharmaceutical treatment for obesity because the Phase 2 clinical trial results, while showing safety and modest efficacy, did not meet the threshold for drug registration
Older Adults Older adults face a higher risk of developing vitamin B12 deficiency as they age
View additional offerings in our research compounds collection
